• Atrium Therapeutics granted inducement equity awards to eight newly hired non-executive employees on June 20.
• Package totals 66,000 non-qualified stock options, exercise price USD 12.66, with 25% vesting at year one then monthly over three years.
• Also issued 33,000 restricted stock units, with 25% vesting at year one then annually over three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrium Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA90548) on June 23, 2026, and is solely responsible for the information contained therein.